Krakow Barry, Ulibarri Victor A, McIver Natalia D, Nadorff Michael R
Sleep & Human Health Institute, 6739 Academy NE, Ste 380, Albuquerque, NM 87109.
Sleep & Human Health Institute, Albuquerque, New Mexico, USA.
Prim Care Companion CNS Disord. 2016 Sep 29;18(5). doi: 10.4088/PCC.16m01980.
Evidence indicates that behavioral or drug therapy may not target underlying pathophysiologic mechanisms for chronic insomnia, possibly due to previously unrecognized high rates (30%-90%) of sleep apnea in chronic insomnia patients. Although treatment studies with positive airway pressure (PAP) demonstrate decreased severity of chronic sleep maintenance insomnia in patients with co-occurring sleep apnea, sleep-onset insomnia has not shown similar results. We hypothesized advanced PAP technology would be associated with decreased sleep-onset insomnia severity in a sample of predominantly psychiatric patients with comorbid sleep apnea.
We reviewed charts of 74 severe sleep-onset insomnia patients seen from March 2011 to August 2015, all meeting American Academy of Sleep Medicine Work Group criteria for a chronic insomnia disorder and all affirming behavioral and psychological origins for insomnia (averaging 10 of 18 indicators/patient), as well as averaging 2 or more psychiatric symptoms or conditions: depression (65.2%), anxiety (41.9%), traumatic exposure (35.1%), claustrophobia (29.7%), panic attacks (28.4%), and posttraumatic stress disorder (20.3%). All patients failed continuous or bilevel PAP and were manually titrated with auto-adjusting PAP modes (auto-bilevel and adaptive-servo ventilation). At 1-year follow-up, patients were compared through nonrandom assignment on the basis of a PAP compliance metric of > 20 h/wk (56 PAP users) versus < 20 h/wk (18 partial PAP users).
PAP users showed significantly greater decreases in global insomnia severity (Hedges' g = 1.72) and sleep-onset insomnia (g = 2.07) compared to partial users (g = 1.04 and 0.91, respectively). Both global and sleep-onset insomnia severity decreased below moderate levels in PAP users compared to partial users whose outcomes persisted at moderately severe levels.
In a nonrandomized controlled retrospective study, advanced PAP technology (both auto-bilevel and adaptive servo-ventilation) were associated with large decreases in insomnia severity for sleep-onset insomnia patients who strongly believed psychological factors caused their sleeplessness. PAP treatment of sleep-onset insomnia merits further investigation.
有证据表明,行为疗法或药物疗法可能未针对慢性失眠的潜在病理生理机制,这可能是由于此前未认识到慢性失眠患者中睡眠呼吸暂停的发生率很高(30%-90%)。尽管采用气道正压通气(PAP)的治疗研究表明,合并睡眠呼吸暂停的患者慢性睡眠维持性失眠的严重程度有所降低,但入睡性失眠并未显示出类似结果。我们假设,在以合并睡眠呼吸暂停的精神科患者为主的样本中,先进的PAP技术将与入睡性失眠严重程度的降低相关。
我们回顾了2011年3月至2015年8月期间就诊的74例严重入睡性失眠患者的病历,所有患者均符合美国睡眠医学学会工作组关于慢性失眠障碍的标准,均确认失眠的行为和心理根源(平均每位患者18项指标中的10项),以及平均有2种或更多精神症状或疾病:抑郁症(65.2%)、焦虑症(41.9%)、创伤暴露(35.1%)、幽闭恐惧症(29.7%)、惊恐发作(28.4%)和创伤后应激障碍(20.3%)。所有患者连续或双水平PAP治疗均失败,并采用自动调压PAP模式(自动双水平和适应性伺服通气)进行人工滴定。在1年随访时,根据每周使用PAP时间>20小时(56名PAP使用者)与<20小时(18名部分PAP使用者)的PAP依从性指标,通过非随机分配对患者进行比较。
与部分使用者相比(分别为g=1.04和0.91),PAP使用者的总体失眠严重程度(Hedges'g=1.72)和入睡性失眠(g=2.07)显著降低。与结果持续处于中度严重水平的部分使用者相比,PAP使用者的总体和入睡性失眠严重程度均降至中度水平以下。
在一项非随机对照回顾性研究中,先进的PAP技术(自动双水平和适应性伺服通气)与强烈认为心理因素导致失眠的入睡性失眠患者失眠严重程度的大幅降低相关。PAP治疗入睡性失眠值得进一步研究。